Covista Inc(CVSA) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:00 PM ET (Korea 9/12 05:00)
Full metrics table
| Index | RUT | P/E | 19.09 | EPS (ttm) | 6.55 | Insider Own | 2.91% | Shs Outstand | 34.0M | Perf Week | -2% |
| Market Cap | 4.26B | Forward P/E | 12.5 | EPS next Y | 10.61% | Insider Trans | -3.37% | Shs Float | 33.0M | Perf Month | -2.44% |
| Enterprise Value | 4.74B | PEG | 1.2 | EPS next Q | 1.83 | Inst Own | 102.07% | Short Float | 5.36% | Perf Quarter | -5.16% |
| Income | 0.27B | P/S | 2.18 | EPS this Y | 9.64% | Inst Trans | -0.2% | Short Ratio | 4.9 | Perf Half Y | 20.46% |
| Sales | 1.95B | P/B | 2.94 | EPS next 5Y | 10.43% | ROA | 9.09% | Short Interest | 1.77M | Perf YTD | 20.89% |
| Book/sh | 42.49 | P/C | 10.06 | EPS past 3/5Y | 52.14% 38.12% | ROE | 18.57% | 52W High | -19.95% ($156.26) | Perf Year | -9.75% |
| Cash/sh | 12.44 | P/FCF | 10.84 | Sales past 3/5Y | 10.44% 16.59% | ROIC | 11.57% | 52W Low | 43.83% ($86.97) | Perf 3Y | 181.99% |
| Dividend Est. | - | EV/EBITDA | 10.03 | EPS Y/Y TTM | 19.32% | Gross Margin | 60.28% | Volatility(W/M) | 3.09% 3.46% | Perf 5Y | 234.11% |
| Dividend TTM | - | EV/Sales | 2.43 | Sales Y/Y TTM | 9.27% | Oper. Margin | 19.94% | ATR (14) | 4.99 | Perf 10Y | 463.21% |
| Dividend Ex-Date | 2016/11/30 | Quick Ratio | 1.09 | EPS Q/Q | 43.25% | Profit Margin | 13.68% | RSI (14) | 44 | Recom | 1.5 |
| Dividend Gr. 3/5Y | - | Current Ratio | 1.09 | Sales Q/Q | 9.69% | SMA20 | -4.72% ($131.29) | Beta | 0.65 | Target Price | $159.5 |
| Payout | - | Debt/Eq | 0.63 | Earnings | 2026/8/6 | SMA50 | -2.3% ($128.03) | Rel Volume | 0.55 | Prev Close | $123.63 |
| Employees | 10680 | LT Debt/Eq | 0.6 | EPS/Sales Surpr. | 10.44% 3.04% | SMA200 | 8.57% ($115.22) | Avg Volume(3M) | 0.36M | Price | $125.09 |
| IPO | 1991/6/21 | Option/Short | Yes/Yes | Trades | 4766 | Volume | 198,558 | Change | 1.18% |
Company
CVSA is a Consumer Defensive sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩺 This is a healthcare education company that provides medical training in the U.S. and the Caribbean region. It operates degree and non-degree programs in nursing, medicine, veterinary medicine, and health/psychology, and owns educational institutions such as Chamberlain, Walden, and Ross. The company is a healthcare education provider exposed to the structural demand driven by shortages of medical professionals.
Over the past 1 year, roughly in the middle
20% below its 1-year high.
CVSA makes money exceptionally well
19.94% of revenue is kept as operating profit.
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +9.6% this year.
Tap to view numbers
The price looks about right
Trading at 19.1 times earnings.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 3 quarters.
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Would have changed by +182.0% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 102.1%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
SAEF 0.02%
PSCD 0.02%
PSL 0.01%
XSHQ 0.01%
FSGS 0.01%It ranks #3 in the industry
Based on market cap of $4B.
CVSA $4B PER 19.1
EDU $9B PER 18.7
LAUR $5B PER 16.2
TAL $4B PER 7.3
FAQ
What kind of company is CVSA?
CVSA belongs to the Consumer Defensive sector and operates in the Education & Training Services industry.
What is the market cap of CVSA?
The market cap of CVSA is approximately $4.3B, ranking 1,511 within its sector.
What is the P/E ratio of CVSA?
CVSA has a P/E ratio of approximately 19.1x, which can be used to assess its valuation relative to the Consumer Defensive sector average.
What is the 52-week high and low for CVSA?
CVSA has recorded a 52-week high of $156.26 and a low of $86.97.
